The Effects and Mechanism of Environmental Enrichment on MK-801 Induced Cognitive Impairment in Rodents with Schizophrenia

Overview

Journal Front Cell Neurosci

Specialty Cell Biology

Date 2022 Oct 17

PMID 36246525

Authors

Jinwei Xu

Yaohao Li

Biqing Tian

Haiying Liu

Shengxi Wu

Wenting Wang

Affiliations

Soon will be listed here.

Abstract

Schizophrenia is a severe mental disorder characterized by positive, negative, and cognitive symptoms. Cognitive symptoms are a kind of symptoms with high incidence and great impact on patients. There is no effective treatment in clinical practice. N-methyl-d-aspartic acid (NMDA) receptor hypofunction may be an important cause of cognitive symptoms. MK-801 (also named Dizocilpine), a noncompetitive antagonist of NMDA receptor, is often used to construct a model of NMDA receptor dysfunction. In terms of treatment, environmental enrichment (EE) as an environmental intervention can effectively improve the symptoms of cognitive impairment in rodents. In this paper, we first briefly introduce the background of cognitive symptoms and EE in schizophrenia, and then investigate the manifestations of MK-801 induced cognitive impairment, the improvement of EE on these cognitive impairments based on the MK-801 induced schizophrenia rodent models, and the possible mechanism of EE in improving cognitive symptoms. This article reviews the literature in recent years, which provides an important reference for MK-801 to construct a cognitive symptom model of schizophrenia and the mechanism of EE in improving cognitive symptoms of schizophrenia.

Citing Articles

Theta-frequency medial septal nucleus deep brain stimulation increases neurovascular activity in MK-801-treated mice.

Crown L, Agyeman K, Choi W, Zepeda N, Iseri E, Pahlavan P Front Neurosci. 2024; 18:1372315.

PMID: 38560047 PMC: 10978728. DOI: 10.3389/fnins.2024.1372315.

Assessing NH300094, a novel dopamine and serotonin receptor modulator with cognitive enhancement property for treating schizophrenia.

Feng Z, Hu Z, Li L, Yu M, Zhang Y, Jing P Front Pharmacol. 2024; 15:1298061.

PMID: 38327987 PMC: 10848157. DOI: 10.3389/fphar.2024.1298061.

Effects of Nicotine Administration in an Enriched Environment on the Behavior of Male MK-801-Exposed Rats.

Salmani N, Darvishzadeh Mahani F, Parvan M, Nozari M Addict Health. 2024; 15(4):260-265.

PMID: 38322486 PMC: 10843354. DOI: 10.34172/ahj.2023.1433.

SHANK3 Mutations Associated with Autism and Schizophrenia Lead to Shared and Distinct Changes in Dendritic Spine Dynamics in the Developing Mouse Brain.

Huang C, Voglewede M, Ozsen E, Wang H, Zhang H Neuroscience. 2023; 528:1-11.

PMID: 37532012 PMC: 10528879. DOI: 10.1016/j.neuroscience.2023.07.024.

Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy.

Ferreira M, Duarte J, Veiga F, Paiva-Santos A, Pires P Pharmaceutics. 2023; 15(2).

PMID: 36840000 PMC: 9959474. DOI: 10.3390/pharmaceutics15020678.

References

Crofton E, Zhang Y, Green T . Inoculation stress hypothesis of environmental enrichment. Neurosci Biobehav Rev. 2014; 49:19-31. PMC: 4305384. DOI: 10.1016/j.neubiorev.2014.11.017. View

Gubert C, Hannan A . Environmental enrichment as an experience-dependent modulator of social plasticity and cognition. Brain Res. 2019; 1717:1-14. DOI: 10.1016/j.brainres.2019.03.033. View

MacQueen D, Young J . The D2-family receptor agonist bromocriptine but, not nicotine, reverses NMDA receptor antagonist-induced working memory deficits in the radial arm maze in mice. Neurobiol Learn Mem. 2020; 168:107159. DOI: 10.1016/j.nlm.2020.107159. View

Ramirez-Rodriguez G, Vega-Rivera N, Meneses-San Juan D, Ortiz-Lopez L, Estrada-Camarena E, Flores-Ramos M . Short Daily Exposure to Environmental Enrichment, Fluoxetine, or Their Combination Reverses Deterioration of the Coat and Anhedonia Behaviors with Differential Effects on Hippocampal Neurogenesis in Chronically Stressed Mice. Int J Mol Sci. 2021; 22(20). PMC: 8535985. DOI: 10.3390/ijms222010976. View

Marques T, Ashok A, Angelescu I, Borgan F, Myers J, Lingford-Hughes A . GABA-A receptor differences in schizophrenia: a positron emission tomography study using [C]Ro154513. Mol Psychiatry. 2020; 26(6):2616-2625. PMC: 8440185. DOI: 10.1038/s41380-020-0711-y. View

Mehrotra S, Pierce M, Cao Z, Jabba S, Gerwick W, Murray T . Antillatoxin-Stimulated Neurite Outgrowth Involves the Brain-Derived Neurotrophic Factor (BDNF) - Tropomyosin Related Kinase B (TrkB) Signaling Pathway. J Nat Prod. 2022; 85(3):562-571. PMC: 9245549. DOI: 10.1021/acs.jnatprod.1c01001. View

Tarres-Gatius M, Lopez-Hill X, Miquel-Rio L, Castarlenas L, Fabius S, Santana N . Discrimination of motor and sensorimotor effects of phencyclidine and MK-801: Involvement of GluN2C-containing NMDA receptors in psychosis-like models. Neuropharmacology. 2022; 213:109079. DOI: 10.1016/j.neuropharm.2022.109079. View

Yu W, Zhu H, Wang Y, Li G, Wang L, Li H . Reactive Transformation and Increased BDNF Signaling by Hippocampal Astrocytes in Response to MK-801. PLoS One. 2015; 10(12):e0145651. PMC: 4689377. DOI: 10.1371/journal.pone.0145651. View

van der Staay F, Rutten K, Erb C, Blokland A . Effects of the cognition impairer MK-801 on learning and memory in mice and rats. Behav Brain Res. 2011; 220(1):215-29. DOI: 10.1016/j.bbr.2011.01.052. View

10.

Xiao X, Xu X, Li F, Xie G, Zhang T . Anti-inflammatory treatment with β-asarone improves impairments in social interaction and cognition in MK-801 treated mice. Brain Res Bull. 2019; 150:150-159. DOI: 10.1016/j.brainresbull.2019.05.017. View

11.

Adell A . Brain NMDA Receptors in Schizophrenia and Depression. Biomolecules. 2020; 10(6). PMC: 7355879. DOI: 10.3390/biom10060947. View

12.

Sears S, Hewett S . Influence of glutamate and GABA transport on brain excitatory/inhibitory balance. Exp Biol Med (Maywood). 2021; 246(9):1069-1083. PMC: 8113735. DOI: 10.1177/1535370221989263. View

13.

Takuma K, Maeda Y, Ago Y, Ishihama T, Takemoto K, Nakagawa A . An enriched environment ameliorates memory impairments in PACAP-deficient mice. Behav Brain Res. 2014; 272:269-78. DOI: 10.1016/j.bbr.2014.07.005. View

14.

Murueta-Goyena A, Ortuzar N, Lafuente J, Bengoetxea H . Enriched Environment Reverts Somatostatin Interneuron Loss in MK-801 Model of Schizophrenia. Mol Neurobiol. 2019; 57(1):125-134. DOI: 10.1007/s12035-019-01762-y. View

15.

Burrows E, McOmish C, Buret L, van den Buuse M, Hannan A . Environmental Enrichment Ameliorates Behavioral Impairments Modeling Schizophrenia in Mice Lacking Metabotropic Glutamate Receptor 5. Neuropsychopharmacology. 2015; 40(8):1947-56. PMC: 4839518. DOI: 10.1038/npp.2015.44. View

16.

Wang X, Hu Y, Liu W, Ma Y, Chen X, Xue T . Molecular Basis of GABA Hypofunction in Adolescent Schizophrenia-Like Animals. Neural Plast. 2021; 2021:9983438. PMC: 8062182. DOI: 10.1155/2021/9983438. View

17.

Girdler S, Confino J, Woesner M . Exercise as a Treatment for Schizophrenia: A Review. Psychopharmacol Bull. 2019; 49(1):56-69. PMC: 6386427. View

18.

Aggleton J, Nelson A . Distributed interactive brain circuits for object-in-place memory: A place for time?. Brain Neurosci Adv. 2020; 4:2398212820933471. PMC: 7479857. DOI: 10.1177/2398212820933471. View

19.

Batinic B . Cognitive Models of Positive and Negative Symptoms of Schizophrenia and Implications for Treatment. Psychiatr Danub. 2019; 31(Suppl 2):181-184. View

20.

Dietz A, Goldman S, Nedergaard M . Glial cells in schizophrenia: a unified hypothesis. Lancet Psychiatry. 2019; 7(3):272-281. PMC: 7267935. DOI: 10.1016/S2215-0366(19)30302-5. View